{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:46:01Z","timestamp":1790156761071,"version":"4.0.1"},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"48","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,11,29]]},"DOI":"10.18632\/oncotarget.12100","type":"journal-article","created":{"date-parts":[[2016,9,17]],"date-time":"2016-09-17T15:18:31Z","timestamp":1474125511000},"page":"78499-78515","source":"Crossref","is-referenced-by-count":17,"title":["A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers"],"prefix":"10.18632","volume":"7","author":[{"given":"Yi-Jen","family":"Lee","sequence":"first","affiliation":[{"name":"Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Cheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Chief of Obstetrics and Gynecology, Tri-Service General Hospital Penghu Branch, Penghu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhy-Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Chief of Pathology, Da-Chien General Hospital, Miaoli, Taiwan"},{"name":"Department of Rehabilitation science, Jente Junior College of Medicine, Nursing and Management, Miaoli, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Chih","family":"Ou","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology, Tri-Service General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chung","family":"Hsu","sequence":"additional","affiliation":[{"name":"Medical Care and Management, Kang-Ning Junior College, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Hsueh","family":"Tseng","sequence":"additional","affiliation":[{"name":"Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ching","family":"Kao","sequence":"additional","affiliation":[{"name":"Department of Biological Science and Technology, China Medical University, Taichung, Taiwan"},{"name":"Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jah-Yao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Defense Medical Center, Taipei, Taiwan"},{"name":"Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,9,17]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2004.09.046","article-title":"Role of pegylated liposomal doxorubicin in ovarian cancer","volume":"96","author":"Rose","year":"2005","journal-title":"Gynecologic oncology"},{"key":"2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Dick","year":"1994","journal-title":"Nature"},{"key":"3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Dick","year":"1997","journal-title":"Nature medicine"},{"key":"4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1471-2407-9-202","article-title":"Breast cancer stem cells: tools and models to rely on","volume":"9","author":"Birnbaum","year":"2009","journal-title":"BMC cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1158\/0008-5472.CAN-04-3931","article-title":"Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer","volume":"65","author":"Kurrey","year":"2005","journal-title":"Cancer research"},{"key":"6","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","article-title":"Identification and characterization of ovarian cancer-initiating cells from primary human tumors","volume":"68","author":"Nephew","year":"2008","journal-title":"Cancer research"},{"key":"7","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1073\/pnas.1120733109","article-title":"Human ovarian cancer stem\/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance","volume":"109","author":"Wei","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"8","doi-asserted-by":"crossref","first-page":"17635","DOI":"10.1074\/jbc.M800109200","article-title":"Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells","volume":"283","author":"Gilad","year":"2008","journal-title":"The Journal of biological chemistry"},{"key":"9","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00262-008-0623-1","article-title":"Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells","volume":"58","author":"Ioannides","year":"2009","journal-title":"Cancer immunology, immunotherapy"},{"key":"10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3727\/096504011X12935427587849","article-title":"Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3","volume":"25","author":"Wang","year":"2011","journal-title":"Oncol Rep"},{"key":"11","first-page":"891","article-title":"Enhanced c-erbB-2\/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A","volume":"53","author":"Hung","year":"1993","journal-title":"Cancer research"},{"key":"12","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ymthe.2004.08.013","article-title":"Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer","volume":"10","author":"Vanderhyden","year":"2004","journal-title":"Molecular therapy"},{"key":"13","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.humpath.2015.05.012","article-title":"Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma","volume":"46","author":"Wang","year":"2015","journal-title":"Human pathology"},{"key":"14","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1530\/REP-14-0234","article-title":"Epithelial ovarian cancer stem cells: underlying complexity of a simple paradigm","volume":"149","author":"Vanderhyden","year":"2015","journal-title":"Reproduction"},{"key":"15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.leu.2404075","article-title":"Target for cancer therapy: proliferating cells or stem cells","volume":"20","author":"Blagosklonny","year":"2006","journal-title":"Leukemia"},{"key":"16","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.4161\/cbt.6.11.5167","article-title":"Cancer stem cell and cancer stemloids: from biology to therapy","volume":"6","author":"Blagosklonny","year":"2007","journal-title":"Cancer biology & therapy"},{"key":"17","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.2174\/092986709788186147","article-title":"Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance","volume":"16","author":"Russo","year":"2009","journal-title":"Current medicinal chemistry"},{"key":"18","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1158\/0008-5472.CAN-07-2673","article-title":"Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation","volume":"68","author":"Schwarzbauer","year":"2008","journal-title":"Cancer research"},{"key":"19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Pegram","year":"2007","journal-title":"Journal of clinical oncology"},{"key":"20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","article-title":"Cancer stem cells in solid tumours: accumulating evidence and unresolved questions","volume":"8","author":"Lindeman","year":"2008","journal-title":"Nature reviews Cancer"},{"key":"21","first-page":"278","article-title":"Cancer stem cells: Implications for cancer causation and therapy resistance","volume":"5","author":"Dean","year":"2005","journal-title":"Discovery medicine"},{"key":"22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1042\/bst0320438","article-title":"Integrin regulation of epidermal growth factor (EGF) receptor and of EGF-dependent responses","volume":"32","author":"Defilippi","year":"2004","journal-title":"Biochemical Society transactions"},{"key":"23","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.2353\/ajpath.2006.060006","article-title":"Individual cell-based models of tumor-environment interactions: Multiple effects of CD97 on tumor invasion","volume":"169","author":"Aust","year":"2006","journal-title":"The American journal of pathology"},{"key":"24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/cb400704n","article-title":"Prometastatic GPCR CD97 is a direct target of tumor suppressor microRNA-126","volume":"9","author":"Tirrell","year":"2014","journal-title":"ACS chemical biology"},{"issue":"276","key":"25","first-page":"re3","article-title":"Sticky signaling\u2014adhesion class G protein-coupled receptors take the stage","volume":"6","author":"Hamann","year":"2013","journal-title":"Science signaling"},{"key":"26","doi-asserted-by":"crossref","first-page":"e88386","DOI":"10.1371\/journal.pone.0088386","article-title":"Down-regulation of Gli transcription factor leads to the inhibition of migration and invasion of ovarian cancer cells via integrin beta4-mediated FAK signaling","volume":"9","author":"Luo","year":"2014","journal-title":"PloS one"},{"key":"27","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.humimm.2014.05.010","article-title":"Up-regulation of DNAM-1 and NKp30, associated with improvement of NK cells activation after long-term culture of mononuclear cells from patients with ovarian neoplasia","volume":"75","author":"Guimaraes","year":"2014","journal-title":"Human immunology"},{"key":"28","article-title":"The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins","author":"Goode","year":"2016","journal-title":"Tumour biology"},{"key":"29","doi-asserted-by":"crossref","first-page":"29167","DOI":"10.1074\/jbc.272.46.29167","article-title":"Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation","volume":"272","author":"Liao","year":"1997","journal-title":"The Journal of biological chemistry"},{"key":"30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/35014038","article-title":"Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor","volume":"2","author":"Volpe","year":"2000","journal-title":"Nature cell biology"},{"key":"31","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1158\/1535-7163.MCT-12-0087","article-title":"FcRL5 as a target of antibody-drug conjugates for the treatment of multiple myeloma","volume":"11","author":"Polson","year":"2012","journal-title":"Molecular cancer therapeutics"},{"key":"32","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1525-1438.2007.01056.x","article-title":"Expression of CD133-1 and CD133-2 in ovarian cancer","volume":"18","author":"Scambia","year":"2008","journal-title":"International journal of gynecological cancer"},{"key":"33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/REP-09-0389","article-title":"Human ovarian cancer stem cells","volume":"140","author":"Bapat","year":"2010","journal-title":"Reproduction"},{"key":"34","first-page":"2591","article-title":"Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins","volume":"53","author":"Bonavida","year":"1993","journal-title":"Cancer research"},{"key":"35","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1002\/cncr.26215","article-title":"Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin","volume":"117","author":"Schwartz","year":"2011","journal-title":"Cancer"},{"key":"36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cc.8.1.7533","article-title":"Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance","volume":"8","author":"Mor","year":"2009","journal-title":"Cell cycle"},{"key":"37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bmc.2006.10.054","article-title":"Linker-modified triamine-linked acridine dimers: synthesis and cytotoxicity propertiesand","volume":"15","author":"Chou","year":"2007","journal-title":"Bioorganic & medicinal chemistry"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T18:18:31Z","timestamp":1657304311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,17]]},"references-count":37,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2016,11,29]]}},"alternative-id":["12100","27655682"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12100","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,17]]}}}